GNI Group Ltd.

2160・Growth Market・Pharmaceuticals

Official website

GNI Group Ltd.

2160・Growth Market・Pharmaceuticals

Official website

GNI Group Ltd.2160

Reference Indicators

Market Cap

1,395¥100M

P/E (Forecast)

—

P/B

2.8x

Dividend Yield (Forecast)

0.00%

ROE

-8.4%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	12,690	17,418	26,010	23,611	26,840
Cost of Sales	1,600	2,674	3,579	5,574	6,847
Gross Profit	11,089	14,744	22,431	18,037	19,993
SG&A Expenses	7,958	10,965	15,292	15,771	18,989
Operating Income	1,624	1,377	13,108	1,402	-3,471
Pre-tax Income	1,107	767	12,612	238	-4,634
Income Taxes	1,051	1,636	3,108	247	2,516
Net Income	1,066	388	8,094	1,098	-4,244
EBITDA	2,007	1,899	13,717	2,385	-2,334
Gross Margin	87.4%	84.6%	86.2%	76.4%	74.5%
Operating Margin	12.8%	7.9%	50.4%	5.9%	-12.9%
ROA	3.5%	1.1%	13.0%	1.5%	-5.1%
ROE	5.7%	1.9%	24.0%	3.0%	-8.4%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医薬品事業	19,158	-4,005	-20.9%
医療機器事業	7,681	533	6.9%